{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T13:03:48Z","timestamp":1785503028831,"version":"3.56.0"},"reference-count":154,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Bladder cancer (BCa) remains one of the most prevalent urological malignancies worldwide and is characterized by high recurrence rates and substantial therapeutic challenges in advanced disease. Exosomes, a nanoscale subtype of extracellular vesicles, have emerged as important mediators of intercellular communication within the tumor microenvironment (TME). This review summarizes the roles of exosomes in BCa progression, immune microenvironment modulation, biomarker development, drug delivery, and immunotherapy, while critically distinguishing preclinical observations from early clinical biomarker evidence. BCa-associated exosomes can promote tumor growth, metastasis, angiogenesis, metabolic reprogramming, and chemoresistance by transferring bioactive cargoes, including microRNAs, long non-coding RNAs, proteins, lipids, and metabolites. Within the tumor immune microenvironment (TIME), BCa-derived exosomes contribute to immune evasion by promoting M2 macrophage polarization, impairing dendritic-cell function, and suppressing natural killer (NK)-cell and T-cell activity. To clarify the context-dependent effects of exosomes, we propose a cargo-context-recipient framework in which exosomal function is determined by the molecular cargo, the biological and therapeutic context, and the functional state of the recipient cell. Because urine provides direct access to bladder-derived vesicles, urinary exosomes show promise as non-invasive diagnostic and prognostic biomarkers, although most studies remain limited by small cohorts and require independent validation. Exosomes also represent potential drug-delivery and immunomodulatory platforms; however, bladder cancer-specific therapeutic evidence remains largely preclinical. Clinical translation is constrained by heterogeneity in exosome isolation and quantification, limited standardization, insufficient mechanistic validation, and a paucity of BCa-specific interventional trials. A more critical, mechanism-guided, and evidence-stratified framework is therefore needed to move exosome research in BCa from descriptive cargo cataloguing toward clinically actionable biomarkers and therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fonc.2026.1821922","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:19:07Z","timestamp":1785500347000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Decoding the role of exosomes in bladder cancer: focusing on tumor progression and immune microenvironment modulation"],"prefix":"10.3389","volume":"16","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Urology, Chengdu Seventh People\u2019s Hospital (Affiliated Cancer Hospital of Chengdu Medical College)","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhuYong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Chengdu Seventh People\u2019s Hospital (Affiliated Cancer Hospital of Chengdu Medical College)","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Chengdu Seventh People\u2019s Hospital (Affiliated Cancer Hospital of Chengdu Medical College)","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: A systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur Urol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70020","article-title":"Top advances of the year: Bladder cancer","volume":"131","author":"Apolo","year":"2025","journal-title":"Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.6160","article-title":"Urinary DNA methylation test for bladder cancer diagnosis","volume":"11","author":"Jeong","year":"2025","journal-title":"JAMA Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.eururo.2011.05.045","article-title":"Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review","volume":"60","author":"van den Bosch","year":"2011","journal-title":"Eur Urol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/ju.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyag027","article-title":"Clinical impact of carboplatin-based neoadjuvant chemotherapy: lack of benefit and surgical delay in muscle-invasive bladder cancer","author":"Kato","year":"2026","journal-title":"Jpn J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00212-24","article-title":"BCG therapy in bladder cancer and its tumor microenvironment interactions","volume":"38","author":"Jian","year":"2025","journal-title":"Clin Microbiol Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/mou.0000000000000601","article-title":"Trimodality therapy for bladder cancer: modern management and future directions","volume":"29","author":"Pham","year":"2019","journal-title":"Curr Opin Urol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: A review","volume":"324","author":"Lenis","year":"2020","journal-title":"Jama"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2020.10.005","article-title":"The tumor microenvironment and immunotherapy in prostate and bladder cancer","volume":"47","author":"Nair","year":"2020","journal-title":"Urol Clin North Am"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2312855121","article-title":"Tumor-neutrophil cross talk orchestrates the tumor microenvironment to determine the bladder cancer progression","volume":"121","author":"Jing","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-cell map of diverse immune phenotypes in the breast tumor microenvironment","volume":"174","author":"Azizi","year":"2018","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13073-023-01164-9","article-title":"Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing","volume":"15","author":"Hu","year":"2023","journal-title":"Genome Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12951-023-02130-8","article-title":"Exosome, the glass slipper for Cinderella of cancer-bladder cancer","volume":"21","author":"Yang","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2025.2541991","article-title":"Advancements in exosome-based cancer diagnosis: from chipsets to nano vaccine","volume":"26","author":"Mukerjee","year":"2025","journal-title":"Cancer Biol Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117296","article-title":"Exosome-based nanoparticles and cancer immunotherapy","volume":"179","author":"Ye","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1554819","article-title":"Unraveling the multifaceted roles of extracellular vesicles in bladder cancer: diagnostic insights and therapeutic opportunities","volume":"15","author":"Huang","year":"2025","journal-title":"Front Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2025.1726884","article-title":"Tumor-derived extracellular vesicles and genitourinary cancers: from biological mechanisms to clinical applications","volume":"13","author":"Wu","year":"2025","journal-title":"Front Bioeng Biotechnol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-00986-3","article-title":"The tumor microenvironment's role in the response to immune checkpoint blockade","volume":"6","author":"Aliazis","year":"2025","journal-title":"Nat Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01111-8","article-title":"Cancer immune evasion, immunoediting and intratumour heterogeneity","volume":"25","author":"Roerden","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32621","article-title":"Urinary exosomes: Potential diagnostic markers and application in bladder cancer","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jncc.2025.04.001","article-title":"The role of exosomes in bladder cancer immunotherapy","volume":"5","author":"Ghasroldasht","year":"2025","journal-title":"J Natl Cancer Center"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02470-z","article-title":"Exosome-mediated metabolic reprogramming: effects on thyroid cancer progression and tumor microenvironment remodeling","volume":"24","author":"Li","year":"2025","journal-title":"Mol Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci16020130","article-title":"Controlling biogenesis and engineering of exosomes to inhibit growth and promote death in glioblastoma multiforme","volume":"16","author":"Alapati","year":"2026","journal-title":"Brain Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09059-y","article-title":"EndoMAP.v1 charts the structural landscape of human early endosome complexes","volume":"643","author":"Gonzalez-Lozano","year":"2025","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2025.102481","article-title":"Organelle homeostasis requires ESCRTs","volume":"93","author":"Lu","year":"2025","journal-title":"Curr Opin Cell Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.01.001","article-title":"The biology, function, and applications of exosomes in cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.tcb.2023.06.006","article-title":"The ins-and-outs of exosome biogenesis, secretion, and internalization","volume":"34","author":"Arya","year":"2024","journal-title":"Trends Cell Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","article-title":"The exosome journey: from biogenesis to uptake and intracellular signalling","volume":"19","author":"Gurung","year":"2021","journal-title":"Cell Commun Signal"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1451988","article-title":"Two roads diverged in a cell: insights from differential exosome regulation in polarized cells","volume":"12","author":"Komori","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021337","article-title":"The machinery of exosomes: biogenesis, release, and uptake","volume":"24","author":"Krylova","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12943-022-01509-9","article-title":"Exosomes as a new frontier of cancer liquid biopsy","volume":"21","author":"Yu","year":"2022","journal-title":"Mol Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2025.07.006","article-title":"Exosome: The hidden messengers in cancer detection and immunotherapy","volume":"43","author":"Sultana","year":"2025","journal-title":"Urol Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116543","article-title":"Research status and challenges of plant-derived exosome-like nanoparticles","volume":"174","author":"Bai","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.05.027","article-title":"Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake","volume":"347","author":"Kimiz-Gebologlu","year":"2022","journal-title":"J Control Release"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.7150\/thno.97096","article-title":"Exosome-like nanoparticles derived from fruits, vegetables, and herbs: innovative strategies of therapeutic and drug delivery","volume":"14","author":"Zhao","year":"2024","journal-title":"Theranostics"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/smsc.202500270","article-title":"Bioengineered extracellular vesicles in emerging cancer vaccine platforms","volume":"5","author":"Ahn","year":"2025","journal-title":"Small Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12032-025-03146-w","article-title":"Exosomal microRNAs as prostate cancer biomarkers and treatments: recent progress","volume":"43","author":"Mahjoubin-Tehran","year":"2025","journal-title":"Med Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102492","article-title":"Targeted inhibition of MDSC-derived exosomal miR-155-5p restrains epithelial-mesenchymal transition in hormone receptor-positive breast cancer by regulating SIRT1","volume":"35","author":"Chen","year":"2025","journal-title":"Mater Today Bio"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102496","article-title":"CD24-targeted cystine and glucose oxidase cascade catalytic nanosystem triggers disulfidptosis in neuroblastoma","volume":"35","author":"Mi","year":"2025","journal-title":"Mater Today Bio"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1007\/s12672-025-03914-0","article-title":"Colorectal cancer cell-derived exosomes induce metabolic reprogramming of cancer-associated fibroblasts to promote colorectal cancer growth","volume":"16","author":"Pan","year":"2025","journal-title":"Discov Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12032-025-03149-7","article-title":"Radiotherapy affects the ELAVL1-mediated autophagy pathway by promoting the release of LINC01943 exosomes in breast cancer cells to accelerate the M2 polarization of macrophages","volume":"43","author":"Wang","year":"2025","journal-title":"Med Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114425","article-title":"Preclinical assessment of genetically modified exosomes for colorectal cancer immunotherapy","volume":"389","author":"Hoang","year":"2025","journal-title":"J Control Release"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2025.11.002","article-title":"Nanotechnology-based cytokine delivery strategies in gastrointestinal cancers","volume":"86","author":"Malik","year":"2025","journal-title":"Cytokine Growth Factor Rev"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-019-03545-4","article-title":"Exosomes: cell-created drug delivery systems","volume":"459","author":"Familtseva","year":"2019","journal-title":"Mol Cell Biochem"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.01.022","article-title":"Exosome-derived circTRPS1 promotes Malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments","volume":"30","author":"Yang","year":"2022","journal-title":"Mol Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c08391","article-title":"Heterogeneous MXene hybrid-oriented exosome isolation and metabolic profiling for early screening, subtyping and follow-up evaluation of bladder cancer","volume":"17","author":"Chen","year":"2023","journal-title":"ACS Nano"},{"key":"B53","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s12672-025-02354-0","article-title":"Machine learning developed immune-related exosome signature for prognosis and immunotherapy benefit in bladder cancer","volume":"16","author":"Luo","year":"2025","journal-title":"Discov Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12943-024-02215-4","article-title":"Emerging role of exosomes in cancer therapy: progress and challenges","volume":"24","author":"Li","year":"2025","journal-title":"Mol Cancer"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1016\/j.cmet.2025.08.012","article-title":"Liver-breast communication of adipocyte-oriented exosomes drives primary mammary cancer progression","volume":"37","author":"Li","year":"2025","journal-title":"Cell Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101275","article-title":"Hypoxia-induced upregulation of HIF1A-AS3 promotes MSC transition to cancer-associated fibroblasts and confers drug resistance in gastric cancer","volume":"82","author":"Xu","year":"2025","journal-title":"Drug Resist Update"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13993","article-title":"Altered levels of miRNA-1290 and lncRNA-H19 in exosomes of patients recently diagnosed with acute lymphoblastic leukemia","volume":"39","author":"Zavala-Reyes","year":"2025","journal-title":"In Vivo"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1432490","article-title":"Current concepts of the crosstalk between lncRNA and E2F1: shedding light on the cancer therapy","volume":"15","author":"Huang","year":"2024","journal-title":"Front Pharmacol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1007\/s12672-025-03793-5","article-title":"Regulatory roles of LncRNAs in colorectal cancer immune evasion: current concepts and future perspectives","volume":"16","author":"Wang","year":"2025","journal-title":"Discov Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101384","article-title":"Urinary exosomal lnc-TAF12-2:1 promotes bladder cancer progression through the miR-7847-3p\/ASB12 regulatory axis","volume":"12","author":"Chen","year":"2025","journal-title":"Genes Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15215305","article-title":"Exosomal long non-coding ribonucleic acid ribonuclease component of mitochondrial ribonucleic acid processing endoribonuclease is defined as a potential non-invasive diagnostic biomarker for bladder cancer and facilitates tumorigenesis via the miR-206\/G6PD axis","volume":"15","author":"Gao","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-13-3512","article-title":"Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties","volume":"74","author":"Ostenfeld","year":"2014","journal-title":"Cancer Res"},{"key":"B63","article-title":"MiR-4644 is upregulated in plasma exosomes of bladder cancer patients and promotes bladder cancer progression by targeting UBIAD1","volume":"12","author":"Yan","year":"2020","journal-title":"Am J Transl Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11292","article-title":"Exosomal miR-663b targets Ets2-repressor factor to promote proliferation and the epithelial-mesenchymal transition of bladder cancer cells","volume":"44","author":"Yin","year":"2020","journal-title":"Cell Biol Int"},{"key":"B65","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12967-022-03508-2","article-title":"Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment","volume":"20","author":"Song","year":"2022","journal-title":"J Transl Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.02.035","article-title":"Bladder cancer exosomes contain EDIL-3\/Del1 and facilitate cancer progression","volume":"192","author":"Beckham","year":"2014","journal-title":"J Urol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s11658-025-00687-w","article-title":"Tumor-derived exosomal KPNA2 activates fibroblasts and interacts with KIFC1 to promote bladder cancer progression, a process inhibited by miR-26b-5p","volume":"30","author":"Yin","year":"2025","journal-title":"Cell Mol Biol Lett"},{"key":"B68","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-030-43093-1_4","article-title":"Oxygen in the tumor microenvironment: mathematical and numerical modeling","volume":"1259","author":"Milotti","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.122895","article-title":"Thrombospondin-4 drives lymphangiogenesis through cooperation with VEGF-C in human bladder cancer","volume":"23","author":"Hwang","year":"2026","journal-title":"Int J Med Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217676","article-title":"Apigenin inhibits recurrent bladder cancer progression by targeting VEGF-\u03b2","volume":"620","author":"Shi","year":"2025","journal-title":"Cancer Lett"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202993","article-title":"Bladder cancer-derived small extracellular vesicles promote tumor angiogenesis by inducing HBP-related metabolic reprogramming and SerRS O-GlcNAcylation in endothelial cells","volume":"9","author":"Li","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.canlet.2021.09.036","article-title":"Secretory autophagy-induced bladder tumour-derived extracellular vesicle secretion promotes angiogenesis by activating the TPX2-mediated phosphorylation of the AURKA-PI3K-AKT axis","volume":"523","author":"Li","year":"2021","journal-title":"Cancer Lett"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.05.005","article-title":"Tumor cell metabolism: cancer's Achilles' heel","volume":"13","author":"Kroemer","year":"2008","journal-title":"Cancer Cell"},{"key":"B74","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41419-025-08289-2","article-title":"Long non-coding RNAs in cancer glycolysis and metabolism: mechanisms and translational opportunities","volume":"17","author":"Ren","year":"2025","journal-title":"Cell Death Dis"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.S314502","article-title":"Regulatory mechanisms of LncRNAs in cancer glycolysis: facts and perspectives","volume":"13","author":"Huang","year":"2021","journal-title":"Cancer Manag Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2912402","article-title":"The Warburg effect: is it always an enemy","volume":"29","author":"Papaneophytou","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2174\/1871520616666161031143301","article-title":"The Warburg effect and the hallmarks of cancer","volume":"17","author":"Schwartz","year":"2017","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5680353","article-title":"Exosome-mediated miR-4792 transfer promotes bladder cancer cell proliferation via enhanced FOXC1\/c-Myc signaling and Warburg effect","volume":"2022","author":"Wu","year":"2022","journal-title":"J Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1097\/ju.0000000000000688","article-title":"Multi-institution evaluation of sequential gemcitabine and docetaxel as rescue therapy for nonmuscle invasive bladder cancer","volume":"203","author":"Steinberg","year":"2020","journal-title":"J Urol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101059","article-title":"Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist Update"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100938","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug Resist Update"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12602","article-title":"FGFR3 alterations in bladder cancer: sensitivity and resistance to targeted therapies","volume":"44","author":"Noeraparast","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13046-025-03330-w","article-title":"Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2","volume":"44","author":"Zhan","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-22-2213","article-title":"Cancer-associated fibroblast-derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance","volume":"83","author":"Zhuang","year":"2023","journal-title":"Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-019-1019-x","article-title":"CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer","volume":"18","author":"Hu","year":"2019","journal-title":"Mol Cancer"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmab023","article-title":"Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p\/ABCB1 axis","volume":"53","author":"Luo","year":"2021","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B87","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s13402-020-00500-0","article-title":"Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt\/\u03b2-catenin pathway and upregulating PTEN","volume":"44","author":"Shan","year":"2021","journal-title":"Cell Oncol (Dordr)"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/bs.ircmb.2024.08.005","article-title":"Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer","volume":"391","author":"Krishnan","year":"2025","journal-title":"Int Rev Cell Mol Biol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2016.10.008","article-title":"Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression","volume":"98","author":"Andreu","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112766","article-title":"Urinary miRNAs as a diagnostic tool for bladder cancer: a systematic review","volume":"10","author":"Grimaldi","year":"2022","journal-title":"Biomedicines"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1186\/s12885-021-08926-x","article-title":"Urinary exosomal miRNAs as biomarkers of bladder cancer and experimental verification of mechanism of miR-93-5p in bladder cancer","volume":"21","author":"Lin","year":"2021","journal-title":"BMC Cancer"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6487","article-title":"Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14969","article-title":"MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma","volume":"8","author":"Matsuzaki","year":"2017","journal-title":"Oncotarget"},{"key":"B94","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12943-018-0893-y","article-title":"Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer","volume":"17","author":"Zhan","year":"2018","journal-title":"Mol Cancer"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.21037\/tau-2025-528","article-title":"Identification of molecular subtypes and prognostic risk model of glucocorticoid-related lncRNAs in bladder cancer to evaluate prognosis and immunological characteristics","volume":"14","author":"Yu","year":"2025","journal-title":"Transl Androl Urol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15438","article-title":"Extracellular vesicles expressing CEACAM proteins in the urine of bladder cancer patients","volume":"113","author":"Igami","year":"2022","journal-title":"Cancer Sci"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.S186108","article-title":"Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer","volume":"10","author":"Yazarlou","year":"2018","journal-title":"Cancer Manag Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S312322","article-title":"Urinary exosomal CA9 mRNA as a novel liquid biopsy for molecular diagnosis of bladder cancer","volume":"16","author":"Wen","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.667212","article-title":"Combination of urine exosomal mRNAs and lncRNAs as novel diagnostic biomarkers for bladder cancer","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.17179\/excli2019-1683","article-title":"Tumor-derived urinary exosomal long non-coding RNAs as diagnostic biomarkers for bladder cancer","volume":"19","author":"Abbastabar","year":"2020","journal-title":"Excli J"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1714460","article-title":"PLGA-based nanoparticles in colorectal cancer immunotherapy: current concepts and future perspectives","volume":"16","author":"Wang","year":"2025","journal-title":"Front Pharmacol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1481296","article-title":"Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12964-025-02297-7","article-title":"ER\u03b1-dependent crosstalk between macrophages and cancer cells potentiates vasculogenic mimicry and M2 macrophage polarization in bladder cancer","volume":"23","author":"Liu","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B104","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12964-021-00768-1","article-title":"Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression","volume":"19","author":"Jiang","year":"2021","journal-title":"Cell Commun Signal"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8268719","article-title":"M2 tumor associate macrophage- (TAM-) derived lncRNA HISLA promotes EMT potential in bladder cancer","volume":"2022","author":"Guo","year":"2022","journal-title":"J Oncol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315177","article-title":"miR-221-5p and miR-186-5p are the critical bladder cancer derived exosomal miRNAs in natural killer cell dysfunction","volume":"23","author":"Huyan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1260498","article-title":"Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval","volume":"14","author":"Martini","year":"2023","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-024-01050-x","article-title":"MicroRNA-enriched exosome as dazzling dancer between cancer and immune cells","volume":"80","author":"Hsu","year":"2024","journal-title":"J Physiol Biochem"},{"key":"B109","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s11658-024-00676-5","article-title":"Exosome-derived proteins in gastric cancer progression, drug resistance, and immune response","volume":"29","author":"Wang","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"B110","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13045-023-01452-2","article-title":"Exosomal circRNA: emerging insights into cancer progression and clinical application potential","volume":"16","author":"Zhang","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.semcancer.2014.05.003","article-title":"Harnessing the exosome-induced immune response for cancer immunotherapy","volume":"28","author":"Gehrmann","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1186\/s12951-024-02952-0","article-title":"Magnetic 3D macroporous MOF oriented urinary exosome metabolomics for early diagnosis of bladder cancer","volume":"22","author":"Cao","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1336375","article-title":"Diagnostic and prognostic potential of exosome non-coding RNAs in bladder cancer: a systematic review and meta-analysis","volume":"14","author":"Chen","year":"2024","journal-title":"Front Oncol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12894-023-01326-2","article-title":"Exosomal miR-105-5p derived from bladder cancer stem cells targets for GPR12 to promote the Malignancy of bladder cancer","volume":"23","author":"Pan","year":"2023","journal-title":"BMC Urol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15384047.2022.2102360","article-title":"BMSC-derived exosomal lncRNA PTENP1 suppresses the Malignant phenotypes of bladder cancer by upregulating SCARA5 expression","volume":"23","author":"Liu","year":"2022","journal-title":"Cancer Biol Ther"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3263","article-title":"Exosome-transmitted microRNA-133b inhibited bladder cancer proliferation by upregulating dual-specificity protein phosphatase 1","volume":"9","author":"Cai","year":"2020","journal-title":"Cancer Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c16629","article-title":"Exosome-inspired lipid nanoparticles for enhanced tissue penetration","volume":"19","author":"Bang","year":"2025","journal-title":"ACS Nano"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4745","article-title":"Evaluating adipose-derived stem cell exosomes as miRNA drug delivery systems for the treatment of bladder cancer","volume":"11","author":"Liu","year":"2022","journal-title":"Cancer Med"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01486-7","article-title":"Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1","volume":"40","author":"Jia","year":"2021","journal-title":"Oncogene"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000347R","article-title":"The role of exosomal miR-375-3p: a potential suppressor in bladder cancer via the Wnt\/\u03b2-catenin pathway","volume":"34","author":"Li","year":"2020","journal-title":"FASEB J"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.09.031","article-title":"Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells","volume":"220","author":"Saari","year":"2015","journal-title":"J Control Release"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2019.10.022","article-title":"Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer","volume":"101","author":"Li","year":"2020","journal-title":"Acta Biomater"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat Rev Genet"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020598","article-title":"Exosome-based carrier for RNA delivery: progress and challenges","volume":"15","author":"Lu","year":"2023","journal-title":"Pharmaceutics"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.11.019","article-title":"Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome","volume":"13","author":"Uddin","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B126","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12951-022-01472-z","article-title":"Recent advances in exosome-mediated nucleic acid delivery for cancer therapy","volume":"20","author":"Zhang","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.7150\/jca.90620","article-title":"Exosome-mediated delivery of artificial circular RNAs for gene therapy of bladder cancer","volume":"15","author":"Zhou","year":"2024","journal-title":"J Cancer"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2016.01.028","article-title":"PLK-1 silencing in bladder cancer by siRNA delivered with exosomes","volume":"91","author":"Greco","year":"2016","journal-title":"Urology"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3390\/cells14221750","article-title":"Exosome-mediated crosstalk between cancer cells and tumor microenvironment","volume":"14","author":"Saad","year":"2025","journal-title":"Cells"},{"key":"B130","volume-title":"Exosomes and Resistance to Immunotherapy in Aggressive Non-Hodgkin B-cell Lymphomas (B-NHL)","year":"2019"},{"key":"B131","volume-title":"A Clinical Study Initiated by Investigator:Prospectively Predict the Efficacy and Explore the Mechanism of Precise Treatment of Gastrointestinal Tumors Based on Peripheral Blood Multi- Omics Liquid Biopsy","year":"2022"},{"key":"B132","volume-title":"Glycosylation of Exosomes in Prostate and Urothelial Carcinoma","year":"2021"},{"key":"B133","volume-title":"A Prospective, Multicenter Cohort Study of Urinary Exosome lncRNAs for Preoperative Diagnosis of Lymphatic Metastasis in Patients With Bladder Cancer","year":"2022"},{"key":"B134","volume-title":"Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits","year":"2023"},{"key":"B135","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-024-01968-2","article-title":"Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by up-regulating fatty acid transporter protein 2 and down-regulating receptor-interacting protein kinase 3 in PMN-MDSCs","volume":"23","author":"Shi","year":"2024","journal-title":"Mol Cancer"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.1c00448","article-title":"Immunotherapy strategy targeting programmed cell death ligand 1 and CD73 with macrophage-derived mimetic nanovesicles to treat bladder cancer","volume":"18","author":"Zhou","year":"2021","journal-title":"Mol Pharm"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167627","article-title":"Exosomal miR-184 facilitates bladder cancer progression by targeting AKR1C3 and inducing immune escape via IRF2-CXCL10 axis","volume":"1871","author":"Ying","year":"2025","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1745178","article-title":"Progress in the application of combined detection of urinary tumor DNA and exosomes in the classification, staging, and clinical management of bladder cancer: a review","volume":"16","author":"Wang","year":"2026","journal-title":"Front Oncol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.104220","article-title":"Clinical relevance of exosome-derived microRNAs in ovarian cancer: looking for new tumor biological fingerprints","volume":"193","author":"Fanale","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70941","article-title":"Role of exosome in solid cancer progression and its potential therapeutics in cancer treatment","volume":"14","author":"Aakel","year":"2025","journal-title":"Cancer Med"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S574708","article-title":"Engineered exosomes: advances in therapeutic applications for otolaryngology-head and neck diseases","volume":"21","author":"Zhu","year":"2026","journal-title":"Int J Nanomedicine"},{"key":"B142","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-025-02372-0","article-title":"Exosomes in cancer nanomedicine: biotechnological advancements and innovations","volume":"24","author":"Liu","year":"2025","journal-title":"Mol Cancer"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17030326","article-title":"Drug delivery systems based on dendritic-cell-derived exosomes","volume":"17","author":"Chen","year":"2025","journal-title":"Pharmaceutics"},{"key":"B144","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1089\/cbr.2025.0050","article-title":"Recent breakthroughs in exosome-based drug delivery: a comprehensive review for cancer therapy","volume":"40","author":"Shah","year":"2025","journal-title":"Cancer Biother Radiopharm"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103222","article-title":"Exosome processing and characterization approaches for research and technology development","volume":"9","author":"Lai","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.7150\/thno.41580","article-title":"Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-021-00693-y","article-title":"Quantitative proteomics identifies the core proteome of exosomes with syntenin-1 as the highest abundant protein and a putative universal biomarker","volume":"23","author":"Kugeratski","year":"2021","journal-title":"Nat Cell Biol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25387","article-title":"Quantification of exosomes","volume":"232","author":"Koritzinsky","year":"2017","journal-title":"J Cell Physiol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41467-023-37403-1","article-title":"Single test-based diagnosis of multiple cancer types using exosome-SERS-AI for early stage cancers","volume":"14","author":"Shin","year":"2023","journal-title":"Nat Commun"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.11.003","article-title":"Immune cell-derived exosomes as promising tools for cancer therapy","volume":"364","author":"Chen","year":"2023","journal-title":"J Control Release"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S444582","article-title":"Engineered exosome for drug delivery: Recent development and clinical applications","volume":"18","author":"Tian","year":"2023","journal-title":"Int J Nanomedicine"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1039\/d3tb01991h","article-title":"Application of exosomes as nanocarriers in cancer therapy","volume":"11","author":"Hu","year":"2023","journal-title":"J Mater Chem B"},{"key":"B153","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12943-024-02045-4","article-title":"Natural killer cell-derived exosome-based cancer therapy: From biological roles to clinical significance and implications","volume":"23","author":"Si","year":"2024","journal-title":"Mol Cancer"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj8207","article-title":"Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy","volume":"8","author":"Zhang","year":"2022","journal-title":"Sci Adv"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1821922\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:19:11Z","timestamp":1785500351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1821922\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":154,"alternative-id":["10.3389\/fonc.2026.1821922"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1821922","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"1821922"}}